Cost-effectiveness and budgetary impact of lipegfilgrastim for the reduction of chemotherapy-induced neutropenia in Brazil

Authors :: Agota Szende
Jean Klastersky
Covance, Leeds, United Kingdom
Udo Mueller
Boxiong Tang
Stephen D. Stefani
Jennifer Urwongse
Erika Szabo
Source :: Jornal Brasileiro de Economia da Saúde. 10:107-117
Publication Year :: 2018
Publisher :: Jornal Brasileiro de Economia da Saude, 2018.

Subjects :: Reduction (complexity)
medicine.medical_specialty
Chemotherapy induced
Cost effectiveness
business.industry
medicine
Budgetary impact
Neutropenia
Intensive care medicine
medicine.disease
business
Lipegfilgrastim

Full Text Access

Tools